MeeraYogarajahMD

Oncology • Bridgeton, MO

Hematologist & Oncologist

Join to view full profile

Dr. Yogarajah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yogarajah's full profile

Already have an account?

Office
12277 De Paul Dr
Ste 100
Bridgeton, MO 63044
Phone+1 314-209-5142

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2019
Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2015 - 2018
One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 2012 - 2015

Certifications & Licensure

MO State Medical License 2019 - 2026
NJ State Medical License 2022 - 2025
MN State Medical License 2018 - 2020
NC State Medical License 2015 - 2019
NY State Medical License 2015 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

3 citations
A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transpl...
Jonathan Webster, Meera Yogarajah, Marianna Zahurak, Heather J. Symons, Amy E. DeZern
Leukemia & Lymphoma. 2021-07-21
11 citations
Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies
Naseema Gangat, Maansi Joshi, Sahrish Shah, Meera Yogarajah, Mrinal M. Patnaik
American Journal of Hematology. 2020-05-01
1 citations
Characteristics of patients with myelodysplastic syndrome with balanced translocations
Maansi Joshi, Patricia T. Greipp, Colleen T. Ball, Mithun Vinod Shah, Arushi Khurana
British Journal of Haematology. 2020-03-17

Lectures

Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Discrepancy of blast percentage between the bone marrow aspirate and biopsy and its impact on survival outcomes in patients with myelodysplastic syndromes excess blast...
2019 ASCO Annual Meeting - 6/1/2019